Aridis: Aridis Pharmaceuticals Announces Adjournment of Annual
LOS GATOS, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) - Aridis Pharmaceuticals, Inc. (OTC QB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating...
Read full article »
Aridis is a California-based biopharmaceutical company that discovers and develops novel anti-infective therapies for the treatment of respiratory infections.
Read more